MABVAX THERAPEUTICS HOLDINGS, INC. — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8217b63b-a5cf-4d6e-b9e2-16bd1b142849/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2017 | $-18.1M | 2017-01-01 – 2017-12-31 | evidence 0001654954-18-003518 |
| FY 2016 | $-16.7M | 2016-01-01 – 2016-12-31 | evidence 0001654954-17-001584 |
| FY 2015 | $-18.1M | 2015-01-01 – 2015-12-31 | evidence 0001415889-16-005062 |
| FY 2014 | $-8.4M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-117877 |
| FY 2013 | $-4.0M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-346213 |
| FY 2012 | $-3.0M | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-346213 |
| FY 2011 | $-12.1M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-081964 |
| FY 2010 | $-26.1M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-081964 |
| FY 2009 | $-24.5M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-081964 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MABVAX THERAPEUTICS HOLDINGS, INC. — all facts · Revenue · Net Income